Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Centene (CNC) Stock Price

Press coverage about Centene (NYSE:CNC) has trended somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Centene earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.4271578445189 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

These are some of the media stories that may have impacted Accern Sentiment Analysis’s analysis:

Several analysts recently weighed in on the company. Morgan Stanley upped their price objective on Centene from $126.00 to $127.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 25th. Zacks Investment Research downgraded Centene from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 10th. ValuEngine upgraded Centene from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Cantor Fitzgerald upped their price objective on Centene from $115.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 7th. Finally, Credit Suisse Group increased their target price on Centene from $110.00 to $112.00 and gave the company a “neutral” rating in a research report on Wednesday, February 7th. Three analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $116.20.

Centene stock traded up $0.14 during trading hours on Thursday, hitting $116.61. The stock had a trading volume of 1,292,800 shares, compared to its average volume of 1,602,311. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $23.75 billion, a PE ratio of 23.18, a P/E/G ratio of 1.12 and a beta of 0.75. Centene has a one year low of $72.14 and a one year high of $117.86.

Centene (NYSE:CNC) last posted its earnings results on Tuesday, April 24th. The company reported $2.17 EPS for the quarter, beating the consensus estimate of $1.92 by $0.25. Centene had a return on equity of 15.69% and a net margin of 2.06%. The firm had revenue of $13.19 billion during the quarter, compared to the consensus estimate of $13.33 billion. During the same period last year, the company earned $1.12 earnings per share. The business’s quarterly revenue was up 12.5% on a year-over-year basis. analysts predict that Centene will post 7.05 earnings per share for the current fiscal year.

In other news, Director Robert K. Ditmore sold 8,750 shares of the firm’s stock in a transaction dated Thursday, April 26th. The stock was sold at an average price of $108.15, for a total transaction of $946,312.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Michael F. Neidorff sold 250,000 shares of the firm’s stock in a transaction dated Thursday, April 26th. The stock was sold at an average price of $108.20, for a total value of $27,050,000.00. The disclosure for this sale can be found here. Insiders have sold 265,550 shares of company stock valued at $28,712,209 over the last 90 days. 3.00% of the stock is owned by corporate insiders.

Centene Company Profile

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs.

Insider Buying and Selling by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply